Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Food and Drug Administration. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. U.S. Department of Health and Human Services FDA; 2009.
2. Johnston B, Patrick D, Devji T, Maxwell L, III CB, Beaton D, et al. Chapter 18: patient-reported outcomes. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane. 2021. www.training.cochrane.org/handbook.
3. Kotecha A, Feuer WJ, Barton K, Gedde SJ. Quality of life in the tube versus trabeculectomy study. Am J Ophthalmol. 2017;176:228–35.
4. Mitchell P, Massin P, Bressler S, Coon CD, Petrillo J, Ferreira A, et al. Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study. Curr Med Res Opin. 2015;31:1967–75.
5. Bressler NM, Chang TS, Suñer IJ, Fine JT, Dolan CM, Ward J, et al. Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR. Ophthalmology. 2010;117:747–56.e4.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献